Clinical Trial Update: A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer [Phase 3]

View source ↗

Summary

A Phase 3 study comparing three regimens—5-FU continuous infusion, irinotecan plus cisplatin, and S-1 alone—in patients with advanced gastric cancer; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-FUci (5-fluorouracil continuous infusion)
• CISPLATIN (cisplatin)
• Irinotecan (Irinotecan)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Japan Clinical Oncology Group | Conditions: Gastric Cancer | Phase 3 | Status: COMPLETED